RUNX1 mutation has no prognostic significance in paediatric AML: a retrospective study of the AML-BFM study group

In acute myeloid leukaemia (AML) RUNX1 mutation is characterised by certain clinicopathological features with poor prognosis and adverse risk by the European LeukemiaNet recommendation. Though initially considered as provisional category, the recent World Health Organisation (WHO) classification of...

Descripción completa

Detalles Bibliográficos
Autores principales: Sendker, Stephanie, Awada, Amani, Domagalla, Sophia, Sendker, Michael, Orhan, Eser, Hoffmeister, Lina Marie, Antoniou, Evangelia, Niktoreh, Naghmeh, Reinhardt, Dirk, von Neuhoff, Nils, Schneider, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317839/
https://www.ncbi.nlm.nih.gov/pubmed/37188777
http://dx.doi.org/10.1038/s41375-023-01919-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317839/
https://www.ncbi.nlm.nih.gov/pubmed/37188777
http://dx.doi.org/10.1038/s41375-023-01919-8

Ejemplares similares